Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride tablets (OTC), 5 mg and 10 mg ("Cetirizine Tablets"). The product will be marketed by Taro’s U.S. affiliate, Taro Pharmaceuticals U.S.A., Inc.
Taro’s Cetirizine Tablets are bioequivalent Read more…
Crack open the latest medical textbook to the chapter on type 2, or adult-onset, diabetes, and you’ll be hard pressed to find the term "immunology" anywhere. This is because metabolic conditions and immunologic conditions are, with a few exceptions, distant cousins.
Buy fluconazole pills However, a group of papers appearing in Nature Medicine, two Read more…
Increasing numbers of children around the world are suffering from respiratory problems - coughing, wheezing and asthma attacks. Although the key external causes of these diseases were identified a long time ago (traffic and industrial air pollution), it had not previously been possible to distinguish clearly between these two factors so as to have a targeted impact on them. Researchers at the Helmholtz Centre for Environmental Research (UFZ) and the University Read more…
Buy soma pills The American Lung Association and the American Academy of Allergy, Asthma & Immunology are partnering to further clinical research to benefit the estimated 40 to 50 million of Americans living with allergic diseases such as asthma.
Through the Allergic Respiratory Diseases Award, the American Lung Association and the American Academy of Allergy, Asthma & Immunology Read more…
Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects. Further respiratory distress was imposed on Zicam users when the FDA also last week announced warnings that the drug may cause a loss of smell.
The manufacturers of the ALCAT Test, a food intolerance test, Read more…